Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D S Baldwin

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
International Clinical Psychopharmacology|September 20, 2000
Clinical experience with paroxetine in social anxiety disorderD S Baldwin
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1982
Clinical usefulness of the morphological classification of lupus nephritisD S Baldwin
Current Pharmaceutical Design|December 17, 2008
Room for improvement in the pharmacological treatment of anxiety disordersD S Baldwin
British Medical Bulletin|November 27, 2001
Depression and sexual dysfunctionD S Baldwin
The American Journal of Medicine|January 1, 1977
Poststreptococcal glomerulonephritis. A progressive disease?D S Baldwin
Transactions of the Association of Life Insurance Medical Directors of America|January 1, 1980
Clinical and Morphologic basis for prognosis in glomerular diseasesD S Baldwin
Kidney International|June 1, 1996
Homer William Smith. January 2, 1895-March 25, 1962. IntroductionD S Baldwin
Kidney International|January 1, 1982
Chronic glomerulonephritis: nonimmunologic mechanisms of progressive glomerular damageD S Baldwin
Clinical and Experimental Dialysis and Apheresis|January 1, 1981
Mechanisms of progression in glomerulonephritisD S Baldwin
Drugs of Today (Barcelona, Spain : 1998)|September 16, 2003
Reboxetine, a selective noradrenaline reuptake inhibitor for the treatment of depressionD S Baldwin, E Carabal
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
International Clinical Psychopharmacology|September 20, 2000
Clinical experience with paroxetine in social anxiety disorderD S Baldwin
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1982
Clinical usefulness of the morphological classification of lupus nephritisD S Baldwin
Current Pharmaceutical Design|December 17, 2008
Room for improvement in the pharmacological treatment of anxiety disordersD S Baldwin
British Medical Bulletin|November 27, 2001
Depression and sexual dysfunctionD S Baldwin
The American Journal of Medicine|January 1, 1977
Poststreptococcal glomerulonephritis. A progressive disease?D S Baldwin
Transactions of the Association of Life Insurance Medical Directors of America|January 1, 1980
Clinical and Morphologic basis for prognosis in glomerular diseasesD S Baldwin
Kidney International|June 1, 1996
Homer William Smith. January 2, 1895-March 25, 1962. IntroductionD S Baldwin
Kidney International|January 1, 1982
Chronic glomerulonephritis: nonimmunologic mechanisms of progressive glomerular damageD S Baldwin
Clinical and Experimental Dialysis and Apheresis|January 1, 1981
Mechanisms of progression in glomerulonephritisD S Baldwin
Drugs of Today (Barcelona, Spain : 1998)|September 16, 2003
Reboxetine, a selective noradrenaline reuptake inhibitor for the treatment of depressionD S Baldwin, E Carabal
Pageof 10